Thalia Therapeutics Plc Logo

Thalia Therapeutics Plc (0GO)

FSX

Currency in EUR
0.00800
0.00 (0.00%)

Real-time Data

06:00 AM

Day's Range

0.00800
0.00800

52 wk Range

0.00050
0.0265

Overview - 0GO - Thalia Therapeutics Plc

Key Statistics

Valuation

Enterprise Value

6.51M

P/E (Trailing)

‪-4.70‬

Price / Sales (TTM)

‪1,955.63‬

Price / Book

‪6.85‬

EV / EBITDA

‪-5.06‬

Profitability

Profit Margin

‪0.00%‬

Operating Margin

‪-19,446.16%‬

Return on Assets

‪-74.91%‬

Return on Equity

‪-140.32%‬

Ownership

Shares Outstanding

832.28M

Float

105.74M

Held by Insiders

‪58.65%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪0.72‬

50-Day Avg

‪0.00483‬

200-Day Avg

‪0.00193‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - 0GO - Thalia Therapeutics Plc

News & Analysis

View all news

Market Cap - 0GO - Thalia Therapeutics Plc

Peers - 0GO - Thalia Therapeutics Plc

Peer Comparison

Compared with companies in Biotechnology listed on FSX.

Profile Summary - 0GO - Thalia Therapeutics Plc

About

Thalia Therapeutics Plc is a biotechnology company developing RNA-based therapeutics and delivery technologies for oncology and cardiovascular disease. The company's proprietary Nuvec delivery system uses amorphous silica nanoparticles with an irregular surface structure designed to trap, protect, and deliver RNA…

SectorHealthcare
IndustryBiotechnology
Employees4
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.